Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly
Sign Up to like & getrecommendations! Published in 2020 at "Endocrine"
DOI: 10.1007/s12020-020-02424-z
Abstract: Recent data indicate that extended dosing intervals (EDIs) with lanreotide autogel 120 mg are effective and well-received among patients with acromegaly who have achieved biochemical control with monthly injections of long-acting somatostatin analogues (SSAs). We further… read more here.
Keywords: lanreotide autogel; autogel 120; control; extended dosing ... See more keywords
LanroNET - A Non-Interventional Prospective Study to Assess the Resource Utilisation and Cost of Lanreotide Autogel 120 mg in the Population of Polish Patients with Symptomatic Neuroendocrine Tumours.
Sign Up to like & getrecommendations! Published in 2018 at "Endokrynologia Polska"
DOI: 10.5603/ep.a2018.0057
Abstract: Wstęp: Celem badania LanroNET była ocena wykorzystania zasobów medycznych oraz kosztów objawowego leczenia polskich chorych na nowotwory neuroendokrynne z zastosowaniem lanreotydu autogel 120 mg. Materiał i metody: LanroNET to wieloośrodkowe, nieinterwencyjne, obserwacyjne, prospektywne badanie przeprowadzone… read more here.
Keywords: odst dzy; chorych; autogel 120; lanronet non ... See more keywords